Literature DB >> 6434113

Oral gold for rheumatoid arthritis.

V Wright.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434113      PMCID: PMC1443414          DOI: 10.1136/bmj.289.6449.858

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  22 in total

1.  Death after taking medicaments.

Authors:  R H Girdwood
Journal:  Br Med J       Date:  1974-03-16

2.  Chrysotherapy. A prospective study.

Authors:  N O Rothermich; V K Philips; W Bergen; M H Thomas
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec

3.  Auranofin: 1 mg or 9 mg? The search for the appropriate dose.

Authors:  A Calin; D Saunders; R Bennett; R Jacox; D Kaplan; W O'Brien; H E Paulus; S Roth; T Weiss
Journal:  J Rheumatol Suppl       Date:  1982 Jul-Aug

4.  Report on a double-blind trial comparing small and large doses of gold in the treatment of rheumatoid disease.

Authors:  J M McKenzie
Journal:  Rheumatol Rehabil       Date:  1981-11

5.  Chrysotherapy in psoriatic arthritis. Efficacy and toxicity compared to rheumatoid arthritis.

Authors:  B B Dorwart; E P Gall; H R Schumacher; R E Krauser
Journal:  Arthritis Rheum       Date:  1978-06

6.  Inhibition of lysosomal enzyme release from rat leukocytes by auranofin. A new chrysotherapeutic agent.

Authors:  M J Dimartino; D T Walz
Journal:  Inflammation       Date:  1977-06       Impact factor: 4.092

7.  Biochemical indices of response to hydroxychloroquine and sodium aurothiomalate in rheumatoid arthritis.

Authors:  J S Dixon; M E Pickup; H A Bird; M R Lee; V Wright; W W Downie
Journal:  Ann Rheum Dis       Date:  1981-10       Impact factor: 19.103

8.  Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.

Authors:  G C Bernhard
Journal:  J Rheumatol Suppl       Date:  1982 Jul-Aug

9.  Maintenance chrysotherapy in rheumatoid arthritis: a comparison of 2 dose schedules.

Authors:  A J Griffin; T Gibson; G Huston; A Taylor
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

10.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11
View more
  5 in total

1.  Nanogold plasmon resonance-based glucose sensing. 2. Wavelength-ratiometric resonance light scattering.

Authors:  Kadir Aslan; Joseph R Lakowicz; Chris D Geddes
Journal:  Anal Chem       Date:  2005-04-01       Impact factor: 6.986

Review 2.  Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?

Authors:  T Pullar
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

Review 3.  The optimum management of arthropathies.

Authors:  C S Wolfe; G R Hughes
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

4.  Gold nanoparticles reduce inflammation in cerebral microvessels of mice with sepsis.

Authors:  Davide Di Bella; João P S Ferreira; Renee de Nazare O Silva; Cinthya Echem; Aline Milan; Eliana H Akamine; Maria H Carvalho; Stephen F Rodrigues
Journal:  J Nanobiotechnology       Date:  2021-02-19       Impact factor: 10.435

5.  Gold nanoparticles as efficient antimicrobial agents for Escherichia coli and Salmonella typhi.

Authors:  Enrique Lima; Roberto Guerra; Víctor Lara; Ariel Guzmán
Journal:  Chem Cent J       Date:  2013-01-19       Impact factor: 4.215

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.